52 letter w e gilbertson fda k bruch dexid inc code let90 docket 75n0183 docket manag branch 53 letter k bruch dexid inc w e gilbertson fda code let91 docket 75n0183 docket manag branch h comment hexachlorophen 13 one comment urg reconsider hexachlorophen otc handwash agent antimicrobi skin cleanser use hospit doctor offic adult consum comment state adequ data support categori statu submit respons advanc notic propos rulemak superfici discuss agenc comment 61 tent final monograph see feder regist januari 6 1978 43 fr 1210 1220 comment submit addit data support safeti hexachlorophen includ retrospect studi 3 percent hexachlorophen babi bath ref 1 studi hexachlorophen blood level infant receiv routin antisept skin care ref 2 comment also includ comprehens review articl safeti effect hexachlorophen ref 3 agenc reevalu data discuss comment 61 tent final monograph 43 fr 1220 evalu new data determin data warrant chang classif hexachlorophen prescript drug infant data ref 1 2 discuss detail tent final monograph otc antimicrobi diaper rash drug product 55 fr 25246 25261 25263 summari handwash studi also submit data includ one studi 3 percent hexachlorophen test surgic scrub exagger use condit ref 4 subject number specifi wash hand forearm 20 ml hexachlorophen 10 minut 5 time daili 6 day week total 58 day sign toxic report blood level hexachlorophen reach plateau within 3 day mean level 0 07 mu g ml agenc believ would necessari test larg group subject number subject requir obtain statist signific result varieti skin condit determin true degre absorpt similar studi review panel 39 fr 33103 33118 report blood level 0 5 mu g ml higher studi subject wash hand face three time daili 3 week either 2 5 ml 3 percent hexachlorophen ref 4 blood concentr reach plateau within 7 day mean level 0 21 mu g ml 2 ml group 0 22 mu g ml 5 ml group